Introduktion
Den här sidan ger en omfattande analys av den kända insiderhandelshistoriken för Craig A Wheeler. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. Det är olagligt för insiders att göra affärer i sina företag baserat på specifik, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4. Trots dessa restriktioner tyder akademisk forskning på att insiders – i allmänhet – tenderar att överträffa marknaden i sina egna företag.
Genomsnittlig handelslönsamhet
Den genomsnittliga handelslönsamheten är den genomsnittliga avkastningen av alla köp på den öppna marknaden som insidern gjort under de senaste tre åren. För att beräkna detta undersöker vi alla oplanerade köp på öppen marknad som görs av insidern, exklusive alla affärer som markerats som en del av en 10b5-1-handelsplan. Vi beräknar sedan den genomsnittliga prestandan för dessa affärer under 3, 6 och 12 månader, med ett genomsnitt av var och en av dessa varaktigheter för att generera ett slutgiltigt resultatmått för varje affär. Slutligen tar vi ett genomsnitt av alla prestationsmått för att beräkna ett prestationsmått för insidern. Denna lista inkluderar endast insiders som har gjort minst tre affärer under de senaste två åren.
Om lönsamheten för denna insiderhandel är "N/A", så har insidern antingen inte gjort några köp på den öppna marknaden under de senaste tre åren, eller så är affärerna de har gjort för nya för att kunna beräkna ett tillförlitligt resultatmått.
Uppdateringsfrekvens: Dagligen
Företag med rapporterade insiderpositioner
SEC-anmälningarna visar att Craig A Wheeler har rapporterat innehav eller affärer i följande företag:
Värdepapper | Titel | Senaste rapporterade innehav |
---|---|---|
US:FOLD / Amicus Therapeutics, Inc. | Director | 84 631 |
US:APLS / Apellis Pharmaceuticals, Inc. | Director | 16 483 |
President & CEO, Director | 0 | |
US:AVNR / Avanir Pharmaceuticals Inc | Director | 400 394 |
Hur man tolkar diagrammen
Följande diagram visar aktieutvecklingen för värdepapper efter varje icke-planerad handel på öppen marknad som görs av Craig A Wheeler. Icke-planerad handel är affärer som inte gjordes som en del av en 10b5-1-handelsplan. Aktieutvecklingen visas som kumulativ procentuell förändring av aktiekursen. Till exempel, om en insiderhandel gjordes den 1 januari 2019, kommer diagrammet att visa den dagliga procentuella förändringen av värdepapperet fram till idag. Om aktiekursen skulle gå från $10 till $15 under denna tid, skulle den kumulativa procentuella förändringen i aktiekursen vara 50%. En förändring i priset från 10 USD till 20 USD skulle vara 100 % och en prisändring på 10 USD till 5 USD skulle vara -50 %.
I slutändan försöker vi avgöra hur nära insiders affärer korrelerar med överavkastning (positiv eller negativ) i aktiekursen för att se om insidern tar tid för sina affärer att dra nytta av insiderinformation. Tänk på situationen där en insider gjorde detta. I den här situationen förväntar vi oss antingen (a) positiv avkastning efter köp eller (b) negativ avkastning efter försäljning. I fallet med (a) skulle KÖP-diagrammet visa en serie uppåtlutande kurvor, vilket indikerar positiv avkastning efter varje köptransaktion. I fallet med (b) skulle SALE-diagrammet visa en serie nedåtlutande kurvor, vilket indikerar negativ avkastning efter varje försäljningstransaktion.
Detta är dock inte tillräckligt för att dra slutsatser. Om till exempel aktiekursen i bolaget var i en icke-cyklisk stigning under många år, skulle vi förvänta oss att alla tomter efter köpet skulle vara uppåtlutande. Likaså skulle icke-cykliska nedgångar under många år resultera i nedåtlutande post-trade tomter. Inget av dessa diagram skulle tyda på insiderhandel.
Den starkaste indikatorn skulle vara en situation där aktiekursen var extremt cyklisk, och det fanns både positiva signaler i KÖP-diagrammet och negativa plotter på SALE-diagrammet. Denna situation skulle i hög grad tyda på en insider som tog tid för affärer till sin ekonomiska fördel.
Insiderköp APLS / Apellis Pharmaceuticals, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i APLS / Apellis Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i APLS / Apellis Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderköp FOLD / Amicus Therapeutics, Inc. - Analys av kortsiktig vinst
I det här avsnittet analyserar vi lönsamheten för varje oplanerat insiderköp på en öppen marknad som görs i APLS / Apellis Pharmaceuticals, Inc.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormal avkastning och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste öppna marknadsköpen som inte var en del av en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till max |
Pris vid max |
Max vinst ($) |
Maximal avkastning (%) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderförsäljning - Analys av kortsiktig förlust
I det här avsnittet analyserar vi det kortsiktiga undvikandet av förluster för varje oplanerad insiderförsäljning på öppen marknad som görs i APLS / Apellis Pharmaceuticals, Inc.. Ett konsekvent mönster för att undvika förluster kan tyda på att framtida försäljningstransaktioner kan förutsäga prisnedgångar. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Följande tabell visar de senaste försäljningarna på den öppna marknaden som inte ingick i en automatisk handelsplan.
Handelsdatum | Ticker | Insider | Rapporterade aktier |
Rapporterad pris |
Justerade aktier |
Justerat pris |
Kostnadsgrund | Dagar till min |
Pris vid min |
Maximal förlust undvikits ($) |
Maximal förlust undvikits ($) |
---|---|---|---|---|---|---|---|
Det finns inga kända oplanerade öppna marknadstransaktioner för denna insider |
Det justerade prisetär det justerade priset efter split. Justerade aktier er de split-justerade aktier.
Insiderhandelshistorik
Den här tabellen visar den fullständiga listan över insideraffärer gjorda av Craig A Wheeler som avslöjats för Securities Exchange Commission (SEC).
Fildatum | Transaktionsdatum | Schema | Ticker | Värdepapper | Kode | Aktier | Återstående aktier | Procentuell förandring | Aktie pris |
Transaktionsvärde | Återstående värde |
|
---|---|---|---|---|---|---|---|---|---|---|---|---|
2025-06-06 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 20 414 | 84 631 | 31,79 | ||||
2025-04-21 |
|
4 | APLS |
Apellis Pharmaceuticals, Inc.
Common Stock |
A - Award | 16 483 | 16 483 | |||||
2024-06-07 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 11 847 | 64 217 | 22,62 | ||||
2023-06-12 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 8 584 | 52 370 | 19,60 | ||||
2022-06-10 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 12 671 | 43 786 | 40,72 | ||||
2021-06-14 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 36 111 | 36 111 | |||||
2021-06-14 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 10 115 | 31 115 | 48,17 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −196 863 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −483 163 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −191 366 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −169 085 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −118 125 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 875 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −132 319 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 681 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −134 433 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −142 051 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 949 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −142 415 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 585 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −3 137 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −7 837 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −6 134 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −15 915 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
D - Sale to Issuer | −5 567 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −250 500 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −100 000 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −37 032 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
D - Sale to Issuer | −11 563 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −389 120 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −48 263 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −36 725 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −8 739 | 0 | −100,00 | ||||
2020-10-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
G - Gift | −190 476 | 389 120 | −32,86 | ||||
2020-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 777 | 15 313 | −15,35 | 28,55 | −79 283 | 437 186 |
2020-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 171 | 37 032 | −14,28 | ||||
2020-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 171 | 18 090 | 51,77 | ||||
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 11 919 | −17,91 | 31,21 | −81 177 | 371 992 |
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 11 563 | −33,33 | ||||
2020-08-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 14 520 | 66,15 | ||||
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −37 575 | 54 664 | −40,74 | 33,32 | −1 251 999 | 1 821 404 |
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 83 500 | 250 500 | 50,00 | ||||
2020-07-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 83 500 | 92 239 | 955,49 | ||||
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −37 575 | 54 664 | −40,74 | 30,56 | −1 148 292 | 1 670 532 |
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 83 500 | 167 000 | 100,00 | ||||
2020-06-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 83 500 | 92 239 | 955,49 | ||||
2020-06-08 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 18 574 | 18 574 | |||||
2020-06-08 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 5 855 | 21 000 | 38,66 | ||||
2020-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 15 313 | −15,36 | 31,23 | −86 757 | 478 225 |
2020-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 172 | 43 203 | −12,50 | ||||
2020-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 18 091 | 51,78 | ||||
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 602 | 11 919 | −17,92 | 32,94 | −85 710 | 392 612 |
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 782 | 17 344 | −25,00 | ||||
2020-05-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 782 | 14 521 | 66,16 | ||||
2020-03-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −347 | 54 664 | −0,63 | 28,75 | −9 976 | 1 571 590 |
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −37 228 | 55 011 | −40,36 | 28,51 | −1 061 370 | 1 568 364 |
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 83 500 | 83 500 | |||||
2020-03-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 83 500 | 92 239 | 955,49 | ||||
2020-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | 21 894 | 0 | −100,00 | |||
2020-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −21 894 | 17 478 | −55,61 | 32,00 | −700 608 | 559 296 |
2020-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 21 894 | 39 372 | 125,27 | 13,26 | 290 314 | 522 073 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 17 478 | −13,71 | 30,82 | −85 618 | 538 672 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 4 581 | 21 894 | 26,46 | ||||
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restriced Stock Units |
A - Award | 6 172 | 49 375 | 14,29 | ||||
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 20 256 | 43,82 | ||||
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 581 | 14 084 | −24,54 | 32,01 | −146 638 | 450 829 |
2020-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 581 | 18 665 | 32,53 | 13,26 | 60 744 | 247 498 |
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −31 178 | 26 475 | −54,08 | |||
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −4 124 | 0 | −100,00 | |||
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 14 084 | −11,18 | 31,89 | −56 541 | 449 139 |
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −35 302 | 15 857 | −69,00 | 32,10 | −1 133 194 | 509 010 |
2020-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 35 302 | 51 159 | 222,63 | 13,26 | 468 105 | 678 368 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 15 857 | −14,09 | 31,43 | −81 749 | 498 386 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 23 126 | −20,00 | ||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 467 | 57 653 | −4,10 | |||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 423 | 4 124 | −37,01 | |||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 200 000 | 200 000 | |||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restriced Stock Units |
A - Award | 100 000 | 100 000 | |||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 18 458 | 45,60 | ||||
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 890 | 12 677 | −27,84 | 32,04 | −156 676 | 406 171 |
2020-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 4 890 | 17 567 | 38,57 | 13,26 | 64 841 | 232 938 |
2020-02-07 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −12 229 | 60 120 | −16,90 | |||
2020-02-07 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −12 229 | 12 677 | −49,10 | 30,21 | −369 438 | 382 972 |
2020-02-07 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 12 229 | 24 906 | 96,47 | 13,26 | 162 157 | 330 254 |
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −15 505 | 72 349 | −17,65 | |||
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −15 505 | 12 677 | −55,02 | 30,04 | −465 770 | 380 817 |
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 15 505 | 28 182 | 122,31 | 13,26 | 205 596 | 373 693 |
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −5 599 | 87 854 | −5,99 | |||
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 599 | 12 677 | −30,64 | 30,02 | −168 082 | 380 564 |
2020-02-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 5 599 | 18 276 | 44,17 | 13,26 | 74 243 | 242 340 |
2019-12-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −8 514 | 0 | −100,00 | |||
2019-12-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −24 820 | 0 | −100,00 | |||
2019-12-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −33 334 | 12 677 | −72,45 | 16,69 | −556 344 | 211 579 |
2019-12-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 33 334 | 46 011 | 262,95 | 15,37 | 512 344 | 707 189 |
2019-11-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −66 666 | 24 820 | −72,87 | |||
2019-11-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −66 666 | 12 677 | −84,02 | 17,00 | −1 133 322 | 215 509 |
2019-11-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 66 666 | 79 343 | 525,88 | 15,37 | 1 024 656 | 1 219 502 |
2019-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 12 677 | −17,97 | 16,25 | −45 142 | 206 001 |
2019-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 172 | 55 547 | −10,00 | ||||
2019-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 15 455 | 66,49 | ||||
2019-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 9 283 | −16,03 | 16,49 | −29 220 | 153 077 |
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 11 055 | −19,05 | 16,16 | −42 032 | 178 649 |
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 28 907 | −16,67 | ||||
2019-11-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 13 656 | 73,41 | ||||
2019-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 16 614 | −14,33 | 11,93 | −33 142 | 198 205 |
2019-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 172 | 61 719 | −9,09 | ||||
2019-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 19 392 | 46,69 | ||||
2019-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 13 220 | −11,83 | 11,74 | −20 815 | 155 203 |
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 14 993 | −14,78 | 11,72 | −30 484 | 175 718 |
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 34 688 | −14,29 | ||||
2019-08-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 17 594 | 48,94 | ||||
2019-07-01 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Stock Options (right to buy) |
A - Award | 19 473 | 19 473 | |||||
2019-07-01 |
|
4 | FOLD |
AMICUS THERAPEUTICS, INC.
Common Stock |
A - Award | 6 250 | 15 145 | 70,26 | ||||
2019-05-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 778 | 20 552 | −11,91 | 13,72 | −38 114 | 281 973 |
2019-05-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −6 172 | 67 891 | −8,33 | ||||
2019-05-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 6 172 | 23 330 | 35,97 | ||||
2019-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 17 158 | −9,36 | 14,13 | −25 038 | 242 443 |
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 18 930 | −12,08 | 13,98 | −36 362 | 264 641 |
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 40 469 | −12,50 | ||||
2019-05-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 21 531 | 36,70 | ||||
2019-04-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −75 000 | 15 750 | −82,64 | ||||
2019-02-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 435 | 177 067 | −0,80 | 14,08 | −20 205 | 2 493 103 |
2019-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −16 875 | 178 502 | −8,64 | 12,67 | −213 806 | 2 261 620 |
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −11 110 | 195 377 | −5,38 | 12,93 | −143 652 | 2 526 225 |
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −24 687 | 74 063 | −25,00 | ||||
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 24 687 | 206 487 | 13,58 | ||||
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 181 800 | −0,97 | 12,84 | −22 765 | 2 334 312 |
2019-02-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 491 000 | 491 000 | |||||
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 183 573 | −1,40 | 11,76 | −30 588 | 2 158 818 |
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 46 250 | −11,11 | ||||
2019-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 186 174 | 3,20 | ||||
2018-11-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 180 393 | −1,08 | 12,38 | −24 376 | 2 233 265 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 182 362 | −0,96 | 12,63 | −22 380 | 2 303 232 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 782 | 52 031 | −10,00 | ||||
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 602 | 184 134 | −1,39 | 14,09 | −36 662 | 2 594 448 |
2018-11-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 782 | 186 736 | 3,20 | ||||
2018-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 183 360 | −1,06 | 27,43 | −54 010 | 5 029 565 |
2018-08-13 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 190 674 | −0,92 | 26,06 | −46 204 | 4 968 964 |
2018-08-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 57 813 | −9,09 | ||||
2018-08-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 192 447 | −1,33 | 28,74 | −74 753 | 5 530 927 |
2018-08-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 195 048 | 3,05 | ||||
2018-06-11 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Option (right to buy) |
A - Award | 8 912 | 8 912 | |||||
2018-06-11 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
A - Award | 3 081 | 8 895 | 52,99 | ||||
2018-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 191 673 | −1,02 | 23,33 | −45 937 | 4 471 731 |
2018-05-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 198 987 | −0,88 | 21,86 | −38 736 | 4 349 856 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | −5 781 | 63 594 | −8,33 | ||||
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 601 | 200 759 | −1,28 | 20,21 | −52 566 | 4 057 339 |
2018-05-10 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 5 781 | 203 360 | 2,93 | ||||
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −33 333 | 0 | −100,00 | |||
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 339 645 | −2,86 | 21,00 | −210 000 | 7 132 545 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −33 333 | 197 579 | −14,44 | 21,00 | −699 993 | 4 149 159 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 33 333 | 230 912 | 16,87 | 10,43 | 347 663 | 2 408 412 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −32 433 | 33 333 | −49,32 | |||
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −5 004 | 349 645 | −1,41 | 20,75 | −103 833 | 7 255 134 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −32 433 | 197 579 | −14,10 | 20,68 | −670 714 | 4 085 934 |
2018-05-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 32 433 | 230 012 | 16,42 | 10,43 | 338 276 | 2 399 025 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −900 | 65 766 | −1,35 | |||
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −4 996 | 354 649 | −1,39 | 21,00 | −104 916 | 7 447 629 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −900 | 197 579 | −0,45 | 21,00 | −18 900 | 4 149 159 |
2018-04-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 900 | 198 479 | 0,46 | 10,43 | 9 387 | 2 070 136 |
2018-04-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −33 334 | 55 269 | −37,62 | |||
2018-04-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 359 645 | −2,71 | 19,00 | −190 000 | 6 833 255 |
2018-04-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −33 334 | 197 579 | −14,44 | 19,00 | −633 346 | 3 754 001 |
2018-04-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 33 334 | 230 913 | 16,87 | 10,43 | 347 674 | 2 408 423 |
2018-02-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 237 900 | −0,82 | 16,45 | −32 390 | 3 913 455 |
2018-02-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 239 869 | −0,81 | 16,46 | −32 410 | 3 948 244 |
2018-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −16 875 | 241 838 | −6,52 | 16,14 | −272 362 | 3 903 265 |
2018-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 197 500 | 197 500 | |||||
2018-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 98 750 | 98 750 | |||||
2018-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 773 | 258 713 | −0,68 | 16,18 | −28 687 | 4 185 976 |
2018-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
M - Exercise | 23 125 | 69 375 | 50,00 | ||||
2018-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 406 | 260 486 | −3,84 | 15,89 | −165 351 | 4 139 123 |
2018-02-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | 23 125 | 275 526 | 9,16 | ||||
2018-01-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −25 666 | 0 | −100,00 | |||
2018-01-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 324 690 | −2,99 | 14,10 | −141 000 | 4 578 129 |
2018-01-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −25 666 | 252 401 | −9,23 | 14,11 | −362 147 | 3 561 378 |
2018-01-03 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 25 666 | 278 067 | 10,17 | 7,41 | 190 185 | 2 060 476 |
2017-11-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 252 401 | −0,81 | 13,35 | −27 474 | 3 369 553 |
2017-11-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 254 459 | −0,80 | 13,34 | −27 454 | 3 394 483 |
2017-11-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 852 | 258 602 | −0,71 | 13,25 | −24 539 | 3 426 476 |
2017-10-02 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −25 667 | 25 666 | −50,00 | |||
2017-10-02 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 282 638 | −3,42 | 19,02 | −190 200 | 5 375 775 |
2017-10-02 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −25 667 | 260 454 | −8,97 | 19,03 | −488 443 | 4 956 440 |
2017-10-02 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 25 667 | 286 121 | 9,85 | 7,41 | 190 192 | 2 120 157 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −14 167 | 51 333 | −21,63 | |||
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −450 | 292 638 | −0,15 | 17,00 | −7 650 | 4 974 846 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −14 167 | 260 454 | −5,16 | 17,00 | −240 839 | 4 427 718 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 14 167 | 274 621 | 5,44 | 7,41 | 104 977 | 2 034 942 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −2 300 | 65 500 | −3,39 | |||
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −3 450 | 293 088 | −1,16 | 17,00 | −58 650 | 4 982 496 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 300 | 260 454 | −0,88 | 17,00 | −39 100 | 4 427 718 |
2017-09-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 2 300 | 262 754 | 0,88 | 7,41 | 17 043 | 1 947 007 |
2017-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 267 173 | −0,76 | 15,07 | −31 014 | 4 026 297 |
2017-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 269 231 | −0,76 | 15,06 | −30 993 | 4 054 619 |
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −9 100 | 67 800 | −11,83 | |||
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 000 | 289 819 | −2,03 | 17,00 | −102 000 | 4 926 923 |
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 853 | 271 289 | −0,68 | 16,47 | −30 519 | 4 468 130 |
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −9 100 | 273 142 | −3,22 | 17,00 | −154 700 | 4 643 414 |
2017-08-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 9 100 | 282 242 | 3,33 | 7,41 | 67 431 | 2 091 413 |
2017-08-04 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −100 | 76 900 | −0,13 | |||
2017-08-04 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 289 100 | −0,03 | 17,00 | −1 700 | 4 914 700 |
2017-08-04 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −100 | 289 100 | −0,03 | 17,00 | −1 700 | 4 914 700 |
2017-08-04 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 100 | 279 961 | 0,04 | 7,41 | 741 | 2 074 511 |
2017-06-15 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Option (right to buy) |
A - Award | 16 236 | 16 236 | |||||
2017-06-15 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Common Stock |
A - Award | 5 814 | 5 814 | |||||
2017-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 279 861 | −0,73 | 15,83 | −32 578 | 4 430 200 |
2017-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 279 861 | −0,73 | 15,83 | −32 578 | 4 430 200 |
2017-05-12 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 852 | 283 977 | −0,65 | 15,77 | −29 206 | 4 478 317 |
2017-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 301 365 | −0,65 | 15,51 | −30 539 | 4 674 171 |
2017-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 301 365 | −0,65 | 15,51 | −30 539 | 4 674 171 |
2017-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 305 303 | −0,55 | 15,51 | −26 181 | 4 735 250 |
2017-02-14 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 088 | 306 991 | −2,26 | 18,85 | −133 609 | 5 786 780 |
2017-02-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Restricted Stock Units |
A - Award | 92 500 | 92 500 | |||||
2017-02-09 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 185 000 | 185 000 | |||||
2016-11-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 764 | 320 699 | −0,55 | 14,05 | −24 784 | 4 505 821 |
2016-11-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 322 463 | −0,63 | 13,52 | −27 824 | 4 359 700 |
2016-11-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | −2 058 | 748 445 | −0,27 | 13,52 | −27 824 | 10 118 976 | |
2016-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 764 | 333 199 | −0,53 | 12,00 | −21 168 | 3 998 388 |
2016-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 334 963 | −0,61 | 12,04 | −24 778 | 4 032 955 |
2016-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 337 021 | −0,61 | 12,03 | −24 758 | 4 054 363 |
2016-06-13 |
|
4 | FOLD |
AMICUS THERAPEUTICS INC
Stock Option (right to buy) |
A - Award | 30 000 | 30 000 | |||||
2016-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 764 | 345 699 | −0,51 | 10,13 | −17 869 | 3 501 931 |
2016-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 347 463 | −0,59 | 10,20 | −20 992 | 3 544 123 |
2016-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 058 | 347 463 | −0,59 | 10,20 | −20 992 | 3 544 123 |
2016-04-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
F - Taxes | −26 608 | 351 579 | −7,04 | 9,69 | −257 832 | 3 406 801 | |
2016-04-15 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 150 000 | 378 187 | 65,74 | ||||
2016-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 244 342 | −0,69 | 9,95 | −16 796 | 2 431 203 |
2016-02-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 875 | 246 030 | −3,10 | 9,37 | −73 789 | 2 305 301 |
2016-02-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 969 | 253 905 | −0,77 | 9,35 | −18 410 | 2 374 012 |
2016-02-18 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 255 874 | −0,66 | 11,30 | −19 074 | 2 891 376 |
2016-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 126 000 | 126 000 | |||||
2016-02-11 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 63 000 | 257 562 | 32,38 | ||||
2015-11-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 200 844 | −0,87 | 17,86 | −31 541 | 3 587 074 |
2015-11-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 061 | 202 610 | −1,01 | 18,05 | −37 201 | 3 657 110 |
2015-11-18 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 204 671 | −0,86 | 17,70 | −31 258 | 3 622 677 |
2015-11-06 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | 41 667 | 83 333 | 100,00 | |||
2015-11-06 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 177 314 | −5,34 | 18,00 | −180 000 | 3 191 652 |
2015-11-06 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −41 667 | 206 437 | −16,79 | 18,00 | −750 006 | 3 715 866 |
2015-11-06 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 41 667 | 248 104 | 20,18 | 16,18 | 674 172 | 4 014 323 |
2015-08-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 212 719 | −0,82 | 22,28 | −39 346 | 4 739 379 |
2015-08-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 061 | 214 485 | −0,95 | 22,02 | −45 383 | 4 722 960 |
2015-08-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 216 546 | −0,81 | 21,77 | −38 446 | 4 714 206 |
2015-06-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −125 000 | 125 000 | −50,00 | |||
2015-06-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −30 000 | 181 032 | −14,22 | 24,11 | −723 300 | 4 364 682 |
2015-06-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −125 000 | 218 312 | −36,41 | 24,22 | −3 027 500 | 5 287 517 |
2015-06-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 125 000 | 343 312 | 57,26 | 16,18 | 2 022 500 | 5 554 788 |
2015-06-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | −83 333 | 250 000 | −25,00 | |||
2015-06-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −20 000 | 211 032 | −8,66 | 22,00 | −440 000 | 4 642 704 |
2015-06-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −83 333 | 218 312 | −27,63 | 22,00 | −1 833 326 | 4 802 864 |
2015-06-05 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 83 333 | 301 645 | 38,17 | 16,18 | 1 348 328 | 4 880 616 |
2015-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 224 594 | −0,78 | 19,68 | −34 755 | 4 420 010 |
2015-05-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 061 | 226 360 | −0,90 | 19,67 | −40 540 | 4 452 501 |
2015-05-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 766 | 228 421 | −0,77 | 19,92 | −35 179 | 4 550 146 |
2015-04-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
M - Exercise | X | 41 667 | 333 333 | 14,29 | |||
2015-04-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −10 000 | 196 308 | −4,85 | 20,00 | −200 000 | 3 926 160 |
2015-04-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −41 667 | 258 629 | −13,88 | 20,00 | −833 340 | 5 172 580 |
2015-04-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
M - Exercise | X | 41 667 | 300 296 | 16,11 | 16,18 | 674 172 | 4 858 789 |
2015-04-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 269 | 258 629 | −2,37 | 18,75 | −117 544 | 4 849 294 |
2015-04-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common tock |
F - Taxes | −27 977 | 264 898 | −9,55 | 17,08 | −477 847 | 4 524 458 | |
2015-04-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
D - Sale to Issuer | −22 125 | 292 875 | −7,02 | ||||
2015-02-25 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 337 769 | −0,62 | 13,52 | −28 527 | 4 566 637 |
2015-02-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 339 879 | −0,49 | 13,37 | −22 569 | 4 544 182 |
2015-02-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −7 875 | 341 567 | −2,25 | 13,52 | −106 470 | 4 617 986 |
2015-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 140 000 | 1 332 000 | 11,74 | 13,02 | 1 822 800 | 17 342 640 | |
2015-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 349 442 | −0,48 | 11,91 | −20 104 | 4 161 854 |
2015-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 70 000 | 351 130 | 24,90 | ||||
2014-11-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 210 | 281 130 | −0,78 | 11,59 | −25 614 | 3 258 297 |
2014-11-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 768 | 364 773 | −0,48 | 11,10 | −19 625 | 4 048 980 |
2014-11-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 768 | 366 541 | −0,48 | 10,58 | −18 705 | 3 878 004 |
2014-08-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 209 | 368 309 | −0,60 | 11,45 | −25 293 | 4 217 138 |
2014-08-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 768 | 370 518 | −0,47 | 11,54 | −20 403 | 4 275 778 |
2014-08-18 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 768 | 372 286 | −0,47 | 11,75 | −20 774 | 4 374 360 |
2014-05-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 374 054 | −0,56 | 12,06 | −25 447 | 4 511 091 |
2014-05-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 376 164 | −0,45 | 12,08 | −20 391 | 4 544 061 |
2014-05-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 687 | 377 852 | −0,44 | 11,09 | −18 709 | 4 190 379 |
2014-02-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 379 539 | −0,55 | 17,47 | −36 844 | 6 630 546 |
2014-02-25 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 750 | 381 648 | −1,74 | 17,68 | −119 340 | 6 747 537 |
2014-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 388 398 | −0,54 | 17,86 | −37 685 | 6 936 788 |
2014-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Righ to Buy) |
A - Award | 140 000 | 1 192 000 | 13,31 | ||||
2014-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 70 000 | 390 508 | 21,84 | ||||
2014-02-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 687 | 320 508 | −0,52 | 17,96 | −30 299 | 5 756 324 |
2014-02-14 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS, INC.
Common Stock |
A - Award | 28 900 | 400 394 | 7,78 | ||||
2013-11-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 215 | 322 195 | −0,68 | 17,77 | −39 361 | 5 725 405 |
2013-11-20 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 215 | 324 410 | −0,68 | 17,17 | −38 032 | 5 570 120 |
2013-11-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 772 | 326 625 | −0,54 | 16,88 | −29 911 | 5 513 430 |
2013-08-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 328 397 | −0,64 | 14,90 | −31 424 | 4 893 115 |
2013-08-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 330 506 | −0,63 | 14,47 | −30 517 | 4 782 422 |
2013-08-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 688 | 332 615 | −0,50 | 15,43 | −26 046 | 5 132 249 |
2013-05-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 334 303 | −0,63 | 13,03 | −27 480 | 4 355 968 |
2013-05-22 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 336 412 | −0,62 | 12,83 | −27 058 | 4 316 166 |
2013-05-17 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −1 687 | 338 521 | −0,50 | 13,33 | −22 488 | 4 512 485 |
2013-02-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 340 208 | −0,62 | 12,58 | −26 531 | 4 279 817 |
2013-02-26 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 342 317 | −0,61 | 12,43 | −26 215 | 4 255 000 |
2013-02-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 344 426 | −0,61 | 12,62 | −26 616 | 4 346 656 |
2013-02-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 150 000 | 1 052 000 | 16,63 | ||||
2013-02-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 60 000 | 346 535 | 20,94 | ||||
2013-02-19 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS, INC.
Common Stock |
A - Award | 38 900 | 371 494 | 11,70 | ||||
2013-02-19 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −6 750 | 286 535 | −2,30 | 12,16 | −82 080 | 3 484 266 |
2012-11-28 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 293 285 | −0,71 | 10,53 | −22 208 | 3 088 291 |
2012-11-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 295 394 | −0,71 | 10,58 | −22 313 | 3 125 269 |
2012-11-21 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 297 503 | −0,70 | 10,96 | −23 115 | 3 260 633 |
2012-08-30 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 299 612 | −0,70 | 14,21 | −29 969 | 4 257 487 |
2012-08-27 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 301 721 | −0,69 | 13,57 | −28 619 | 4 094 354 |
2012-08-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 303 830 | −0,69 | 13,63 | −28 746 | 4 141 203 |
2012-05-31 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 331 719 | −0,63 | 13,79 | −29 097 | 4 574 405 |
2012-05-25 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 333 829 | −0,63 | 13,98 | −29 484 | 4 666 929 |
2012-05-23 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 335 938 | −0,62 | 14,15 | −29 856 | 4 753 523 |
2012-03-01 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 322 580 | −0,65 | 15,00 | −31 635 | 4 838 700 |
2012-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −8 438 | 324 689 | −2,53 | 15,45 | −130 367 | 5 016 445 |
2012-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 110 | 333 127 | −0,63 | 15,45 | −32 600 | 5 146 812 |
2012-02-24 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
S - Sale | X | −2 109 | 335 237 | −0,63 | 15,07 | −31 783 | 5 052 022 |
2012-02-17 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS, INC.
Common Stock |
A - Award | 30 000 | 327 594 | 10,08 | ||||
2012-02-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Stock Option (Right to Buy) |
A - Award | 150 000 | 902 000 | 19,95 | ||||
2012-02-16 |
|
4 | MNTA |
MOMENTA PHARMACEUTICALS INC
Common Stock |
A - Award | 60 000 | 337 346 | 21,63 | ||||
2007-03-05 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS
Class A Common Stock |
A - Award | 11 752 | 50 683 | 30,19 | ||||
2007-03-05 |
|
4 | AVNR |
AVANIR PHARMACEUTICALS
Class A Common Stock |
A - Award | 32 496 | 38 931 | 504,99 | ||||
2006-02-15 |
|
4 | AVN |
AVANIR PHARMACEUTICALS
Class A Common Stock |
A - Award | 6 435 | 6 435 |